Postep w zwalczaniu klasycznego pomoru swin

• Autorzy: Truszczynski M , Pejsak Z.

Warianty tytułu

EN

Progress in controlling classical swine fever

• Języki publikacji: PL

Abstrakty

EN

Classical swine fever (CSF) is a worldwide economically important, highly contagious disease of swine. Poland has been free of this disease for the last 14 years. However, outbreaks occur in neighboring countries and create serious risks. Therefore, it seems essential to present the progress of laboratory diagnosis and vaccines. Since the CSF virus reservoir in wild boars is important for the infection of domestic swine, this topic has also been presented. The paper also describes diagnostic techniques for identifying the agents and serological tests for detecting the virus - it characterizes specific antibodies, including an assessment of their diagnostic value. Recent developments of CSF vaccines are discussed, including the live, lapinised vaccine, containing the attenuated Chinese C strain of CSF and marker vaccines, developed with the application of molecular biology and genetic engineering techniques. These vaccines, despite being less effective than the C-strain vaccine, enable to discriminate infected animals from vaccinated ones (DIVA strategy) when correspondent diagnostic kits are used. These detect antibodies which are exclusively characteristic for antigens of the vaccine strain or antibodies specific to antigens of the virulent CSF virus. Procedures of controlling CSF in wild boars were described including recommendations of diagnostic tests and oral vaccinations.

Słowa kluczowe

PL

pomor klasyczny swin; trzoda chlewna; rezerwuary zarazka; szczepienia ochronne; testy diagnostyczne; zwalczanie chorob zwierzat; wirus klasycznego pomoru swin; choroby zwierzat; szczepionki; identyfikacja; wykrywanie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2008
• Tom: 64
• Numer: 02
• Opis fizyczny: s.127-131,rys.,tab.,bibliogr.

Twórcy

autor

Truszczynski M

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Pejsak Z.

Bibliografia

• 1.Biront P., Leunen J., Vandeputte: Inhibition of virus replication in the tonsils of pigs previously vaccinated with Chinese strain vaccine and challenged oronasally with a virulent strain of clssical swine fever virus. Vet. Microbiol. 1987, 14, 105-113.
• 2.Blome S., Maindl-Böhmer A., Loeffen W., Thuer B., Moennig V.: Assessment of classical swine fever diagnostics and vaccine performance. Rev. sci. tech. Off. Int Epiz. 2006, 25, 1025-1038.
• 3.Bouma A., de Smit A. J., de Jong M. C., de Kluijver E. P., Morrmann R. J.: Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine 2000, 18, 1374-1381.
• 4.Bouma A., de Smit A. J., de Kluijver E. P., Terpstra C., Moormann R. J.: Efficacy and stability of a ubunit vaccinebased on glicoprotein E2 of classical swine fever virus. Vet. Microbiol. 1999, 66, 101-114.
• 5.Commission of the European Communities - Commission Decision approving a Diagnostic Manual establishing diagnostic procedures, sampling methods and criteria for evolution of the laboratory tests for the confirmation of classical swine fever. Off. J. Eur. Communities 2002, L, 39, 71-88.
• 6.Commission of the European Communities (2001) Council Directive 2001/89/EC on Community measures for the control of classical swine fever. 23 October Off. J. Eur. Communities L. 316, 5-35.
• 7.Diagnostic techniques and vaccines for foot-and-mouth, classical swine fever, avian influenza and some other important OIE List A Diseases. European Commission 2003, 1-150.
• 8.Dong X. D., Chen Y. H.: Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 2006, w druku i www science-direct corm/locate/Vaccine.
• 9.Floegel-Niesmann G., Moennig V.: Quality management in reference tests for the diagnosis of classical swine fever. Rev. sci. tech. Off. Int. Epiz. 2004, 23, 899-903.
• 10.Hulst M. M., Westra D. F., Wensvoort G., Moormann R. J.: Glicoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Viral. 1993, 67, 5435-5442.
• 11.Kaden V., Heyne H., Kiupel H., Letz W., Lemmerll., Gorsler K., Rothe A., Böhme H., Typre P.: Oral immunisation of wild boar against classical swine fever: concluding analusis of the recent field trials in Germany. Berl. Münch. Tierärztl. Wochenschr. 2002, 115, 179-185.
• 12.Kaden V., Kramer M., Kern B., Hlinak A., Mewes L., Händel A., Renner Ch., Dedek J., Bruer W.: Diagnostic procedures after completion of oral immunisation against classical swine fever in wild boar. Rev. sci. tech. Off. Int. Epiz. 2006, 25, 989-997.
• 13.Konig M., Lengsfeld T., Pauly T., Stark R., Thiel H. J.: Classical swine fever independent induction of protective immunity by two structural glicoproteins. J. Virol. 1995, 69, 6479-6486.
• 14.Leunen J., Strobbe R.: Capacity of attenuated swine fever vaccines to prevent virus carriers in the vaccinated pigs, after contact with field virus. Arch. Exp. Veterinärmed. 1978, 31, 533-536.
• 15.McGoldrick A., Lowings J. P., Ibata G., Sands J. J., Belak S., Paton D. J.: A novel approach to the detection of classical swine fever virus by RT-PCR with a fluorogenic probe. J. Virol. Methods 1998, 72, 125-135.
• 16.Moormann R. J., Bouma A., Kramps J. A., Terpstra C., De Smit H. J.: Development of the classical swine fever subunit marker vaccine and comparison diagnostic test. Vet. Microbiol. 2000, 73, 209-219.
• 17.Narita M., Kawashima K., Kimura K., Mikami O., Shibahara T., Yamada S., Sakoda Y.: Comparative immunohistopathology in pigs infected with highly virulent or less virulent strains of hog cholera virus. 2000, 37, 402-408.
• 18.OIE International Terrestrial Animal Health Cocle 2005.
• 19.OIE Manual of Doagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees), Fifth Edition 2004.
• 20.OIE Quality Standard and Guidelines for Veterinary Laboratories: Infectious Diseases 2003, OIE Paris, 1-63.
• 21.Piriou L., Chevallier S., Hutet E., Charley B., LePotier M. F., Albina E.: Humoral and cell mediated immune response of d/d histocompatible pigs against classical swine fever (CSF) virus. Vet. Res. 2003, 34, 389-404.
• 22.Report on the evaluation of a new classical swine fever discriminatory test. European Commission Directorate General for Health and Consumer Protection, Brussels 2003, 1-71.
• 23.Risatti G., Holinka L., Lu Z., Kutish G., Callahan J. D., Nelson W. M., Brece T. E., Borea M. V.: Diagnostic evaluation of real time reverse transcriptase PCR assay for detection of classical swine fever virus. J. Clin. Microbiol. 2005, 43, 468-471.
• 24.Rissati G. R., Borca M. V., Kutish G. F., Lu Z., Holinka L. G., French R. A.: The E2 glicoprotein of classical swine fever virus is a virulence determinant in swine. J. Virol. 2005, 79, 3787-3796.
• 25.Van Oirst J. T.: Vaccinology pf classical swine fever: from lab to field. Vet. Microbiol. 2003, 96, 367-384.
• 26.Weiland E., Stark R., Haas B., Rumenapf., Meyers G., Thiel H. J.: Pestivirus glycoprotein which induces neutralizing antibodies forms part of the disulfide - linked heterodimer. J. Virol. 1990, 64, 3563-3569.